Relation Between Ethanol Sclerotherapy for Endometrioma Systemic Immune Milieu

• Status: Completed
• Trial end date: 2022-05-19
• Target enrollment: 0
• Participant gender: Female

Summary

Design: Prospective interventional study. 69 women with OE were evaluated clinically and by transvaginal ultrasonography (TUV). AEST procedure was performed and the collected aspirate and pre-procedural blood samples were collected for estimation of cytokines' levels. At 6-m post-procedure, clinical evaluation and TUV were repeated and serum cytokines' levels were re-estimated.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Ethanol

Criteria

Inclusion Criteria:

• Women with OE of a mean diameter of >3 cm

Exclusion Criteria:

• Women with recurrent OE

• a cyst that was suspicious of being malignant

• diabetes mellitus

• polycystic ovary syndrome

• body mass index (BMI) of >30 kg/m2

• previous surgical interference that resulted in pelvic adhesions